The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...
First Novel Schizophrenia Treatment in Decades Gains FDA Approval
The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...
The American Journal of Managed Care2 天
First Schizophrenia Treatment Approved in Decades Targets Cholinergic Receptors
Formally known as KarXT, xanomeline-trospium chloride (Cobenfy) receives approval from the FDA for the treatment of ...
The Manila Times on MSN2 天
New approved treatment for schizophrenia emerges
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...
FDA Approves Potentially Groundbreaking Schizophrenia Drug
On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...
New Hampshire Union Leader3 天
A new heated treatment for stomach cancer
My husband has late-stage stomach cancer, and we’ve heard there’s a new treatment for it, something called HIPEC. What is ...
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...
WBBM Radio Chicago on MSN2 天
FDA approves new treatment for schizophrenia
With Thursday approval from the U.S. Food and Drug Administration for Cobenfy, adults living with schizophrenia will have ...
Health experts list seven warning signs of heart disease which is 'number one killer for women'
Doctors say that if something feels off or unusual, women should not hesitate to contact a GP as regular check-ups can help ...
FDA approves 1st new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
Business Wire2 天
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...